Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness.
The long-term treatment of manic-depressive illness (MDI) likely involves the strategic regulation of signalling pathways and gene expression in critical neuronal circuits. Accumulated evidence has identified signalling pathways, in particular the family of protein kinase C (PKC) isozymes, as targets for the long-term action of lithium. Chronic lithium administration produces a reduction in the expression of PKC alpha and epsilon, as well as a major PKC substrate, MARCKS, which has been implicated in long-term neuroplastic events in the developing and adult brain. More recently, studies have demonstrated robust effects of lithium on another kinase system, GSK-3beta, and on neuroprotective/neurotrophic proteins in the brain. Given the key roles of these signalling cascades in the amplification and integration of signals in the central nervous system, these findings have clear implications not only for research into the neurobiology of MDI, but also for the future development of novel and innovative treatment strategies.
Manji
H K
HK
Department of Psychiatry, Wayne State University School of Medicine, Detroit, Michigan 48201, USA. hmanji@med.wayne.edu
McNamara
R
R
Chen
G
G
Lenox
R H
RH
D000328:Adult; D018692:Antimanic Agents / Q000494:pharmacology; D001714:Bipolar Disorder / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology*; D001921:Brain / Q000502:physiology; D006801:Humans; D007527:Isoenzymes; D016651:Lithium Carbonate / Q000494:pharmacology; D011493:Protein Kinase C / Q000378:metabolism*; D015398:Signal Transduction
D018692:Antimanic Agents; D007527:Isoenzymes; D016651:Lithium Carbonate; D011493:Protein Kinase C